THRX

Theseus Pharmaceuticals, Inc. Common Stock

Delisted

THRX was delisted on the 13th of February, 2024.

51 hedge funds and large institutions have $97.5M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+4
Holders Change %
+8.51%
% of All Funds
0.86%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
7
Increased
23
Reduced
11
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
UBS Group
51
UBS Group
Switzerland
-$24K -2,041 Closed